Home Newsfeeds Morgan Stanley Maintains Equal-Weight on SEMrush Hldgs, Lowers Price Target to $13

Morgan Stanley Maintains Equal-Weight on SEMrush Hldgs, Lowers Price Target to $13

Morgan Stanley analyst Elizabeth Porter maintains SEMrush Hldgs (NYSE:SEMR) with a Equal-Weight and lowers the price target from $16 to $13.

byBenzinga Newsdesk

November 16, 2022

1 minute read

Morgan Stanley analyst Elizabeth Porter maintains SEMrush Hldgs (NYSE:SEMR) with a Equal-Weight and lowers the price target from $16 to $13.

News
Tech

Google Pixel 8 Vs Pixel 7: Six Changes That Make Pixel 8 Worth The Wait

By Rounak Jain

August 31, 6:37 AM

If you are wondering whether to wait for the Pixel 8 or buy the Pixel 7 now, read on to find out what to do.

AAPL

Lloyds Banking Plans To Cut Job In Risk Management Division: Report

By Lekha Gupta

April 10, 10:11 AM

Lloyds Banking Group reportedly plans to restructure risk management division, resulting in 175 job cuts. Meanwhile, the company is reportedly creating more than 100 new roles requiring more technical expertise.

APIE

Here’s How Much You Would Have Made Owning Global Tech Industries Gr Stock In The Last 5 Years

By Benzinga Insights

November 24, 2:04 PM

Global Tech Industries Gr (OTC:GTII) has outperformed the market over the past 5 years by 113.41% on an…

GTII

SI-BONE Announces FDA Clearance For Expanded Rod Compatibility With The iFuse Bedrock Granite Implant System

By Benzinga Newsdesk

December 27, 9:35 AM

SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced an additional FDA clearance for iFuse Bedrock

SIBN

Morgan Stanley Maintains Equal-Weight on SEMrush Hldgs, Lowers Price Target to $13

Related Posts

Google Pixel 8 Vs Pixel 7: Six Changes That Make Pixel 8 Worth The Wait

Lloyds Banking Plans To Cut Job In Risk Management Division: Report

Here’s How Much You Would Have Made Owning Global Tech Industries Gr Stock In The Last 5 Years

SI-BONE Announces FDA Clearance For Expanded Rod Compatibility With The iFuse Bedrock Granite Implant System